Moderna Stock Sees Healthy Relative Strength Rating

Moderna (MRNA) stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 67 to 73.   How To Invest In Stocks In Both Bull And Bear Markets IBD’s proprietary RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that shows how a stock’s price performance over the last…